Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2022Open Access

Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study.

View Full Paper
Ask AI
Bookmark
Share

Authors

PBPascal BenkertSMStéphanie MeierSSSabine Schaedelin

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Benkert et al. (2022) studied this question.

synapsesocial.com/papers/6a829cefd88fdfcf4fa0c177https://doi.org/10.48350/165754
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis2017 · 1,195 citations
  2. 2Confounding effect of blood volume and body mass index on blood neurofilament light chain levels2020 · 255 citations
  3. 3Serum neurofilament light levels in normal aging and their association with morphologic brain changes2020 · 592 citations
  4. 4New insights into the burden and costs of multiple sclerosis in Europe: Results for Switzerland2017 · 42 citations
  5. 5Serum neurofilament light in atrial fibrillation: clinical, neuroimaging and cognitive correlates2020 · 49 citations